Gostout Christopher J. 4
4 · Apollo Endosurgery, Inc. · Filed May 11, 2020
Insider Transaction Report
Form 4
Gostout Christopher J.
Chief Medical Officer
Transactions
- Award
Common Stock
2020-05-07+34,561→ 67,327 total - Award
Stock Option (Right to Buy)
2020-05-07$2.08/sh+51,610$107,349→ 229,552 totalExercise: $2.08Exp: 2030-05-07→ Common Stock (51,610 underlying)
Footnotes (2)
- [F1]Represents the grant of Restricted Stock Units ("RSU"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock pursuant to the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan. The RSUs vest in equal annual installments over three years commencing on the grant date, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Incentive Plan.
- [F2]The shares underlying the option shall vest as to 33% on the first anniversary of the grant date and the remainder will vest in equal monthly installments over the following two years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan.